Dynavax Technologies Corp (DVAX)
11.76
-0.08
(-0.68%)
USD |
NASDAQ |
Apr 23, 16:00
11.75
-0.01
(-0.09%)
After-Hours: 20:00
Dynavax Technologies Price to Book Value: 2.467 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 2.486 |
| April 19, 2024 | 2.478 |
| April 18, 2024 | 2.381 |
| April 17, 2024 | 2.400 |
| April 16, 2024 | 2.412 |
| April 15, 2024 | 2.454 |
| April 12, 2024 | 2.486 |
| April 11, 2024 | 2.522 |
| April 10, 2024 | 2.509 |
| April 09, 2024 | 2.524 |
| April 08, 2024 | 2.530 |
| April 05, 2024 | 2.530 |
| April 04, 2024 | 2.536 |
| April 03, 2024 | 2.560 |
| April 02, 2024 | 2.585 |
| April 01, 2024 | 2.641 |
| March 28, 2024 | 2.606 |
| March 27, 2024 | 2.606 |
| March 26, 2024 | 2.597 |
| March 25, 2024 | 2.625 |
| March 22, 2024 | 2.580 |
| March 21, 2024 | 2.553 |
| March 20, 2024 | 2.541 |
| March 19, 2024 | 2.524 |
| March 18, 2024 | 2.457 |
| Date | Value |
|---|---|
| March 15, 2024 | 2.530 |
| March 14, 2024 | 2.524 |
| March 13, 2024 | 2.555 |
| March 12, 2024 | 2.654 |
| March 11, 2024 | 2.723 |
| March 08, 2024 | 2.759 |
| March 07, 2024 | 2.692 |
| March 06, 2024 | 2.673 |
| March 05, 2024 | 2.639 |
| March 04, 2024 | 2.675 |
| March 01, 2024 | 2.679 |
| February 29, 2024 | 2.660 |
| February 28, 2024 | 2.719 |
| February 27, 2024 | 2.728 |
| February 26, 2024 | 2.759 |
| February 23, 2024 | 2.677 |
| February 22, 2024 | 2.612 |
| February 21, 2024 | 2.616 |
| February 20, 2024 | 2.578 |
| February 16, 2024 | 2.584 |
| February 15, 2024 | 2.599 |
| February 14, 2024 | 2.599 |
| February 13, 2024 | 2.559 |
| February 12, 2024 | 2.669 |
| February 09, 2024 | 2.690 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.087
Minimum
Mar 17 2023
83.73
Maximum
Jun 26 2020
13.09
Average
7.331
Median
Oct 07 2020
Price to Book Value Benchmarks
| Supernus Pharmaceuticals Inc | 1.779 |
| Ligand Pharmaceuticals Inc | 1.768 |
| Pacira BioSciences Inc | 1.432 |
| Esperion Therapeutics Inc | -- |
| PetIQ Inc | 2.191 |
Price to Book Value Related Metrics
| PS Ratio | 7.128 |
| Price to Free Cash Flow | 17.16 |
| Price | 11.76 |
| Earnings Yield | -0.51% |
| Market Cap | 1.536B |
| Normalized PE Ratio | 1076.20 |